Google's Huber to Lead Illumina Cancer-Detecting Startup Grail
- Developing `liquid biopsies' for early tumor diagnosis
- Grail raised more than $100 million in venture capital
This article is for subscribers only.
Google Inc. executive Jeff Huberwill depart the technology giant to head up Grail, Illumina Inc.’s startup that’s developing a blood test to spot cancers in their earliest stages.
Huber, an Illumina director since 2014, spent 12 years at Google, where he worked on advertising products, as well as Google Maps, Google Earth and most recently the life sciences arm of Google X.